Skip to content

Organic Patents®

A WordPress site dedicated to Patents and Organic Chemistry

  • Home
  • About
  • Enablement
  • Obviousness
    • Cases from the CAFC & PTAB on Small-Molecule Obviousness
    • Obviousness of Chemical Processes
    • Obviousness of Stereoisomers & Purified Compounds
  • Patent Eligibility
  • DISCLAIMER
  • Boilerplate Definitions

USPTO Goes to 11! (11,000,000)

USPTO Issues patent #11,000,000

https://www.uspto.gov/about-us/news-updates/uspto-issues-patent-number-11000000

Share:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to print (Opens in new window) Print
This entry was posted in Uncategorized on May 11, 2021 by David Rucando.

Post navigation

← Another §101 Update from the USPTO (Subject Matter Eligibility) Sanofi’s Jevtana® (cabazitaxel) Not Obvious over Docetaxel →

Links

  • ACS-Chemistry & The Law
  • US Patent & Trademark Office
  • Patently-O
  • PatentDocs
  • PharmaPatents Blog

Recent Posts

  • SCHRÖDINGER’S POLYMORPH: WHEN A CRYSTALLINE FORM CLAIM IS OBVIOUS AND INVALID
  • NESACS Advances in Chemical Sciences Symposium
  • 10-Month Rule: Federally Funded Provisional Patent Applications
  • Inherency & Therapeutic Mechanisms: Reviewing In re Couvaras – (With No-Frills Diagrams)

Archives

Categories

  • Case Law
  • Chemistry
  • Deals
  • Education
  • Fun Facts
  • FYI
  • Interesting Patents
  • Patent Prosecution
  • SCOTUS
  • U.S. Supreme Court
  • Uncategorized
  • USPTO

Contact

david@organicpatents.com

Proudly powered by WordPress
Exit mobile version